1. Introduction {#sec1}
===============

Gap junctional intercellular communication (GJIC) is an important biological mechanism to maintain homeostasis, growth, differentiation, and development of cells and tissues \[[@B1]\]. Gap junctions are made of two hemichannels, called connexons, and each in turn is composed of six molecules of the membrane-spanning connexin (Cx) protein \[[@B2], [@B3]\].

The gap junctions of human keratinocytes include primarily Cx43, which is abundantly expressed within interfollicular epidermis, and Cx26, which is codistributed with Cx43 in skin \[[@B4]\]. Several studies showed that the downregulation of Cxs and phosphorylation of Cxs are involved in the carcinogenesis of the skin \[[@B4], [@B5]\]. Cx43 is phosphorylated by several protein kinases, such as protein kinase C (PKC), casein kinase 1, and mitogen-activated protein kinase (MAPK) \[[@B3], [@B6]--[@B8]\]. Recent evidence suggests that the carcinogenicity of oxidative stress induced by H~2~O~2~ is attributable to the inhibition of GJIC \[[@B8]--[@B10]\].

Melatonin, an indoleamine (N-acetyl-5 methoxytryptamine), produced especially at night in the pineal gland \[[@B11], [@B12]\], has antioxidant \[[@B13], [@B14]\], anti-inflammatory \[[@B15], [@B16]\], antidepressant \[[@B17]\], and antitumor activities against various cancers \[[@B18]--[@B20]\]. Though melatonin was recently shown to regulate GJIC in chick astrocyte \[[@B21]\], mouse hepatocytes \[[@B22]\], and MCF-7 breast cancer cells \[[@B23], [@B24]\], the underlying molecular mechanism by melatonin via GJIC regulation in human keratinocyte HaCaT cells still remains unclear. Thus, in the present study, the molecular mechanism responsible for GJIC regulation by melatonin was examined in human keratinocyte HaCaT cells using the MTT assay, scrape-loading assay, RT-PCR, western blotting, and flow cytometric analysis for reactive oxygen species (ROS).

2. Materials and Methods {#sec2}
========================

2.1. Chemicals and Reagents {#sec2.1}
---------------------------

Melatonin (molecular weight: 232), dimethylsulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), protease inhibitor cocktail, Lucifer Yellow, Trizol reagent, MMLV, Taq polymerase, vitamin C, and 2,7-dichlorofluorescein diacetate (DCFDA) fluorescence dye were purchased from Sigma-Aldrich (St. Louis, MO, USA). Primers (Cx26, Cx30, and Cx43) were purchased from Cosmogenetech (Seoul, Republic of Korea). Dulbecco\'s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), and antibiotic-antimycotic agent were obtained from Welgene (Daegu, Republic of Korea). Sodium dodecyl sulfate (SDS) was purchased from Amresco (Solon, OH, USA). RC DC protein assay kit was purchased from Bio-Rad (Hercules, CA, USA). Dimethylformamide was obtained from Merck KGaA (Darmstadt, Germany). Enhanced chemiluminescence (ECL) detection reagent was purchased from Amersham Pharmacia (Piscataway, NJ, USA). Phospho-JNK, JNK phospho-p38 MAPK, p38 MAPK, phospho-ERK, and ERK antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). Cx26, Cx30, Cx43, and phospho-Cx43 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). *β*-actin was purchased from Sigma-Aldrich (St. Louis, MO, USA). Melatonin was dissolved in DMSO (2 M stock solution). In all experiments, DMSO concentration was kept below 0.2% (v/v) to remove the cytotoxic effect of solvent DMSO.

2.2. Cell Culture {#sec2.2}
-----------------

Human keratinocyte HaCaT cells were purchased from American Type Culture Collection (Manassas, VA, USA) and maintained in DMEM supplemented with 10% FBS and penicillin/streptomycin.

2.3. Cytotoxicity Assay {#sec2.3}
-----------------------

The cytotoxicity of melatonin was measured by MTT colorimetric assay. HaCaT cells were seeded onto 96-well microplates at a density of 1 × 10^4^ cells per well and treated with various concentrations of melatonin for 24 h. MTT working solution (5 mg/mL in PBS) was added to each well and incubated at 37°C for 3 h. The optical density (OD) was then measured at 570 nm using a microplate reader (Sunrise, TECAN, Männedorf, Switzerland). Cell viability was calculated as a percentage of viable cells in melatonin or H~2~O~2~-treated group versus untreated control by the following equation: cell viability (%) = \[OD (melatonin) − OD (blank)\]/\[OD(Control) − OD (Blank)\] × 100.

2.4. Scrape-Loading Dye-Transfer Assay {#sec2.4}
--------------------------------------

GJIC of the cells was assessed by the scrape-loading dye-transfer (SLDT) technique described by EL-Fouly et al. \[[@B25]\] with some modifications. HaCaT cells (cell confluency; 80--90%) incubated in 35 mm dishes for 24 h were treated with H~2~O~2~ (300 *μ*M) or melatonin (1 or 2 mM), respectively. Following incubation, the cells were washed twice with 2 mL of PBS. Lucifer Yellow was added to the washed cells, and three scrapes were made with a surgical steel-bladed scalpel at low-light intensities. Three scrapes were performed to ensure that the scrape traversed a large group of confluent cells. After 3 min incubation, the cells were washed with 10 mL of PBS and then fixed with 2 mL of a 4% formalin solution. The distance traveled by the dye in a direction perpendicular to the scrape was observed with an inverted Axio Axiovert S 100 fluorescent microscope (Carl Zeiss).

2.5. Total RNA Isolation and RT-PCR Analysis {#sec2.5}
--------------------------------------------

Total RNA was prepared by using Trizol reagent according to the manufacturer\'s instructions. Total RNA (1.0 *μ*g) was reverse transcribed using MMLV reverse transcriptase (Promega, Madison, WI, USA) by incubation at 25°C for 10 min, at 42°C for 60 min, and at 99°C for 5 min. The synthesized cDNA was amplified using TaKaRa Taq DNA polymerase (TaKaRa Biotechnology, Shiga, Japan) and the following specific primers: *Cx26* (sense 5′-TCTTTTCCAGAGCAAACCGC-3′; antisense 5′-CTGGGCAATGAGTTAAACTGG-3′), *Cx30* (sense 5′-GCAGCATCTTTTTCCGAATC-3′; antisense 5′-ATGCTCCTTTGTCAAGACGT-3′), *Cx43* (sense 5′-TACCATGCGACCAGTGGTGCGCT-3′, antisense 5′-GAATTCTGGTTATCATCGGGGAA-3′), and *GAPDH* (sense 5′-GTGGATATTGTTGCCATCA-3′, antisense 5′-ACTCATACAGCACCTCAG-3′). PCR conditions were 30 cycles of 96°C for 30 sec, 55°C for 30 sec, and 72°C for 30 sec, followed by 5 min incubation at 72°C. PCR products were run on 2% agarose gel and then stained with ethidium bromide (EtBr).

2.6. Measurement of Reactive Oxygen Species (ROS) Production {#sec2.6}
------------------------------------------------------------

ROS level was measured using 2,7-dichlorofluorescein diacetate (DCFDA) fluorescence dye. Cells were incubated with 1 *μ*M DCFDA at 37°C for 30 min. Fluorescence intensity was measured by BD FACSCalibur flow cytometry (Becton Dickinson, Franklin Lakes, NJ).

2.7. Western Blotting {#sec2.7}
---------------------

Cells (1 × 10^6^ cells/mL) were treated with various concentrations of melatonin (0, 1, or 2 mM) for 24 h, lyzed in lysis (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 mM EDTA, 1 mM Na~3~VO~4~, 1 mM NaF, and 1x protease inhibitor cocktail) on ice, and spun down at 14,000 ×g for 20 min at 4°C. The supernatants were collected and quantified for protein concentration by using RC DC protein assay kits (Bio-Rad, Hercules, CA, USA). The protein samples were separated on 4--12% NuPAGE Bis-Tris gels (Novex, Carlsbad, CA, USA) and transferred to a Hybond ECL transfer membrane for detection with antibodies for Cx26, Cx30, Cx43 and phosphor-Cx43 (Santa Cruz Biotechnologies, Santa Cruz, CA, USA), phospho-JNK, JNK, phospho-p38 MAPK, p38 MAPK, phospho-ERK, and ERK (Cell signaling Technology, Beverly, MA, USA), and *β*-actin (Sigma, St. Louis, MO, USA).

2.8. Statistical Analyses {#sec2.8}
-------------------------

All data were expressed as means ± SD. The statistically significant differences between control and melatonin-treated groups were calculated by ANOVA test followed by a post hoc analysis (Tukey or Dunnett\'s multiple-comparison test) using Prism software 5 (GraphPad Software, Inc., San Diego, CA, USA).

3. Results {#sec3}
==========

3.1. Melatonin and H~2~O~2~ Exerted Weak Cytotoxicity in HaCaT Cells {#sec3.1}
--------------------------------------------------------------------

To determine nontoxic concentrations of melatonin and H~2~O~2~, the cytotoxic effects of melatonin and H~2~O~2~ were evaluated in HaCaT cells by MTT assay. Cells were exposed to various concentrations of melatonin (0, 0.25, 0.5, 1, 2, or 4 mM) and H~2~O~2~ (0, 150, 300, or 600 *μ*M) for 24 h, and then MTT assay was performed. As shown in Figures [1(b)](#fig1){ref-type="fig"} and [1(c)](#fig1){ref-type="fig"}, melatonin and H~2~O~2~ showed weak cytotoxic effect in HaCaT cells. Thus, a concentration of 300 *μ*M H~2~O~2~ was used for all experiments.

3.2. Melatonin Reduced ROS Production and Facilitated the Decreased GJIC Activity in H~2~O~2~-Treated HaCaT Cells {#sec3.2}
-----------------------------------------------------------------------------------------------------------------

H~2~O~2~ is well known to produce free radicals to inhibit gap junctional intercellular communication \[[@B26]\]. As shown in [Figure 2(a)](#fig2){ref-type="fig"}, melatonin reduced ROS production to 5.83% compared to H~2~O~2~-treated control (22%) in HaCaT cells. Consistently, melatonin enhanced intercellular communication disturbed by H~2~O~2~ in HaCaT cells by scrape-loading dye-transfer assay as shown in Figures [2(c)](#fig2){ref-type="fig"} and [2(d)](#fig2){ref-type="fig"}.

3.3. Melatonin Significantly Enhanced the Expression of Cx26 and Cx43 at mRNA and Protein Levels, but Not That of Cx30 in H~2~O~2~-Treated HaCaT Cells {#sec3.3}
------------------------------------------------------------------------------------------------------------------------------------------------------

The phosphorylation of the gap junction protein Cx43 is directly associated to functional GJIC \[[@B27]\]. To investigate the effect of melatonin on connexins at mRNA and protein levels in H~2~O~2~-treated HaCaT cells, RT-PCR and western blot analyses were carried out. As shown in Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}, mRNA levels of Cx26 and Cx43 were reduced by H~2~O~2~-alone treatment, while melatonin enhanced the mRNA level of them in H~2~O~2~-treated HaCaT cells. mRNA level of Cx30 did not change in H~2~O~2~- or melatonin-treated cells. Consistently, melatonin increased the protein level of Cx26 and Cx43 in H~2~O~2~-treated HaCaT cells (Figures [3(d)](#fig3){ref-type="fig"} and [3(e)](#fig3){ref-type="fig"}). We also observed that melatonin suppressed the phosphorylation of Cx43 in H~2~O~2~-treated HaCaT cells ([Figure 3(c)](#fig3){ref-type="fig"}).

3.4. Melatonin Significantly Decreased the Phosphorylation of ERK Alone, but Not p38 MAPK or JNK in H~2~O~2~-Treated HaCaT Cells {#sec3.4}
--------------------------------------------------------------------------------------------------------------------------------

The effect of melatonin on MAPK signaling was investigated in H~2~O~2~-treated HaCaT cells. Melatonin attenuated the phosphorylation of ERK, but did not significantly affect that of p38 MAPK and JNK in H~2~O~2~-treated HaCaT cells, while H~2~O~2~ activated the phosphorylation of ERK, p38, and JNK proteins as shown in Figures [4(a)](#fig4){ref-type="fig"} and [4(b)](#fig4){ref-type="fig"}. Next, in order to confirm that the GJIC by H~2~O~2~ is mediated by ERK pathway, we used the ERK inhibitor PD98059. As shown in Figures [4(c)](#fig4){ref-type="fig"} and [4(d)](#fig4){ref-type="fig"}, ERK inhibitor PD98059 effectively recovered the decreased activity of GJIC in H~2~O~2~-treated HaCaT cells.

3.5. Combined Treatment of Melatonin and Vitamin C at Low Concentrations Exerted the Synergy in Reducing ROS Production in H~2~O~2~-Treated HaCaT Cells {#sec3.5}
-------------------------------------------------------------------------------------------------------------------------------------------------------

In order to evaluate the synergistic effect of melatonin with other antioxidant, we used vitamin C. As shown in [Figure 5(a)](#fig5){ref-type="fig"}, melatonin (200 *μ*M) or vitamin C (10 *μ*g/mL) alone at low concentration did not affect Cx34 in H~2~O~2~-treated HaCaT cells. In contrast, combined treatment of melatonin and vitamin C promoted the expression of Cx34. Similarly, though melatonin at 2 mM suppressed ROS generation induced by H~2~O~2~, low concentration (200 *μ*M) of melatonin did not affect ROS production as in [Figure 5(b)](#fig5){ref-type="fig"}. As shown in [Figure 5(b)](#fig5){ref-type="fig"}, melatonin (200 *μ*M) or vitamin C (10 *μ*g) alone did not affect ROS production, but combination of melatonin and vitamin C significantly reduced ROS production to 16.15% compared to H~2~O~2~-treated control (23.56%).

4. Discussion {#sec4}
=============

H~2~O~2~ plays an important role in the multistep process of carcinogenesis and directly promotes transformation in many *in vivo* and *in vitro* model systems \[[@B32]--[@B34]\]. In the present study, melatonin suppressed ROS production and facilitated H~2~O~2~-mediated inhibition of GJIC in HaCaT cells, implying the antioxidant and anti-carcinogenic potential of melatonin, which was supported by previous studies that the carcinogenicity of H~2~O~2~ is attributable to the inhibition of GJIC \[[@B35]\]. Likewise, antioxidants such as vitamin C and quercetin protect against the disruption of GJIC induced by H~2~O~2~ \[[@B36]\].

There are several lines of evidences that malignant lesions reveal abnormal expression of connexins and decreased GJIC \[[@B37]--[@B39]\]. The function of GJIC can be modulated at the multi-stages during the turnover of connexins by transcriptional, translational, and posttranscriptional mechanisms. Hence, prevention or inhibition of decreased GJIC can be an important target for cancer therapy. As suggested, H~2~O~2~ induced downregulation of connexins, thereby disrupting the GJIC system \[[@B5]\]. Here we found that melatonin recovered the reduced phosphorylation of Cx26 and Cx43 induced by H~2~O~2~ at protein and mRNA levels, but not that of Cx30 in H~2~O~2~-treated HaCaT cells, indicating that melatonin regulates GJIC via activation of Cx26 and Cx43 signaling.

MAPKs are considered to play important roles in GJIC \[[@B40]\]. Also, ROS-activated MAPK cascades phosphorylate the various proteins involved in cell growth and development \[[@B41]\]. Previous studies revealed that H~2~O~2~-dependent ERK and p38 kinase activation lead to depressed GJIC and enhanced connexin degradation \[[@B40]\]. However, in the current study, melatonin significantly decreased the phosphorylation of ERK alone, but not p38 MAPK or JNK. Furthermore, ERK inhibitor PD98059 effectively recovered the lowered activity of GJIC in H~2~O~2~-treated HaCaT cells, suggesting the critical role of ERK in recovering the decreased GJIC activity by H~2~O~2~. Interestingly, combined treatment of melatonin (200 *μ*M) and vitamin C (10 *μ*g/mL) that do not affect ROS production significantly reduced ROS production in H~2~O~2~-treated HaCaT cells, implying the synergistic effect of melatonin and vitamin C at low concentrations. However, it is also required to confirm this synergistic effect in small animals or humans in the near future.

In summary, melatonin showed weak cytotoxicity in HaCaT cells, reduced ROS production, recovered the disturbed GJIC, enhanced the expression of Cx26 and Cx43 at mRNA and protein levels, suppressed the phosphorylation of ERK, and enhanced synergy with vitamin C in H~2~O~2~-treated HaCaT cells ([Figure 6](#fig6){ref-type="fig"}). Overall, our findings suggest that melatonin recovers decreased GJIC via enhancement of Cx26 and Cx43 and inhibition of ROS production and ERK phosphorylation.
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![Chemical structure and cytotoxicity of melatonin. (a) Chemical structure of melatonin. Cytotoxicity of melatonin (b) and H~2~O~2~ (c) in HaCaT cells. Cytotoxicity of melatonin and H~2~O~2~ was evaluated in HaCaT cells by MTT assay. Cells were plated onto 96-well microplates (1 × 10^4^ cells/well) and treated with various concentrations of melatonin (0, 0.25, 0.5, 1, 2, or 4 mM) and H~2~O~2~ (0, 150, 300, or 600 *μ*M) for 24 h. Data were expressed as means ± SD of three independent experiments.](ECAM2012-589365.001){#fig1}

![Melatonin reduced ROS production and facilitated the decreased GJIC activity in H~2~O~2~-treated HaCaT cells. (a) Cells were exposed to H~2~O~2~ (300 *μ*M) with or without melatonin (2 mM) for 24 h. ROS generation (%) was measured using ROS-sensitive fluorometric probe 2,7-dichlorofluorescein diacetate (DCFDA) by flow cytometric analysis. (b) Quantified graph for ROS production. Data represent means ± SD. ^\#\#^ *P* \< 0.01 versus untreated control. \*\*\**P* \< 0.001 versus melatonin treated cells. (c) GJIC was assessed using the scrape-loading/dye-transfer (SL/DT) method under an inverted fluorescence microscope (100x). (d) Quantification of recovery rate.](ECAM2012-589365.002){#fig2}

![Melatonin significantly enhanced the expression of Cx26 and Cx43 at mRNA and protein levels, but not that of Cx30 in H~2~O~2~-treated HaCaT cells. (a) Cells were exposed to H~2~O~2~ (300 *μ*M) with or without melatonin (1 or 2 mM) for 24 h. (a) mRNAs expressions of Cx26, Cx30, and Cx43 were analyzed by RT-PCR. Grapes represent relative level of Cx26, Cx30, and Cx43/GAPDH. (b) Quantification of mRNAs expression. Phosphorylation of Cx43 (c) and protein expressions of Cx26, Cx30, and Cx43 (d) in melatonin-H~2~O~2~-treated cells were analyzed by western blot. (e) Grapes represent relative level of Cx26, Cx30, and Cx43/*β*-actin.](ECAM2012-589365.003){#fig3}

![Melatonin significantly decreased the phosphorylation of ERK alone, but not p38 MAPK or JNK in H~2~O~2~-treated HaCaT cells. Cells were exposed to H~2~O~2~ (300 *μ*M) with or without melatonin (1 or 2 mM) for 24 h. (a) Western blotting was performed for phospho-ERK, ERK, phospho-p38, p38, phospho-JNK, and JNK. (b) Graphs represent relative level of phospho-ERK/ERK, phospho-p38/p38, and phospho-JNK/JNK. (c) Effect of ERK inhibitor PD98059 on GJIC using the SL/DT method. (d) Quantification of recovery rate.](ECAM2012-589365.004){#fig4}

![Combined treatment of melatonin and vitamin C at low concentrations exerted the synergy in reducing ROS production in H~2~O~2~-treated HaCaT cells. H~2~O~2~-treated HaCaT cells were exposed in the absence or presence of melatonin (200 *μ*M), vitamin C (10 *μ*g/mL), and melatonin plus vitamin C for 24 h. (a) Western blotting was performed for Cx43 and *β*-actin. (b) ROS generation (%) was measured using ROS-sensitive fluorometric probe 2,7-dichlorofluorescein diacetate (DCFDA) by flow cytometric analysis. Graph represents quantification for ROS production.](ECAM2012-589365.005){#fig5}

![Molecular mechanism of melatonin facilitated GJIC in H~2~O~2~-treated HaCaT cells.](ECAM2012-589365.006){#fig6}
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